Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Okuno

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
Journal of Human Hypertension|April 4, 2014
A subtype prediction score for primary aldosteronismK Nanba, M Tsuiki, K Nakao, et al.
Sarcoma|June 4, 2008
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasM von Mehren, S P Balcerzak, A S Kraft, et al.
Cancer|June 1, 1997
A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositisS H Okuno, R L Foote, C L Loprinzi, et al.
Frontiers in Oncology|December 5, 2025
Case Report: Should IGF-1R targeted therapy be revisited in Ewing sarcoma? a report of long-term complete response and review of the literatureGeorgios M Stergiopoulos, Brittany L Siontis, Safia K Ahmed, et al.
Cancers|September 28, 2024
Tolerability and Outcomes for Treatment of Older Myxoid Liposarcoma PopulationReilly A Coombs, Judith Jebastin Thangaiah, Brittany L Siontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
American Journal of Clinical Oncology|June 17, 2017
Extraskeletal Osteosarcoma: Outcomes and the Role of ChemotherapyJonas Paludo, Karen Fritchie, Candace L Haddox, et al.
Annals of Surgical Oncology|November 15, 2007
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysisImran Hassan, Y Nancy You, Roman Shyyan, et al.
Oncology|June 1, 2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaKristen N Ganjoo, Lee D Cranmer, James E Butrynski, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
Journal of Human Hypertension|April 4, 2014
A subtype prediction score for primary aldosteronismK Nanba, M Tsuiki, K Nakao, et al.
Sarcoma|June 4, 2008
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasM von Mehren, S P Balcerzak, A S Kraft, et al.
Cancer|June 1, 1997
A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositisS H Okuno, R L Foote, C L Loprinzi, et al.
Frontiers in Oncology|December 5, 2025
Case Report: Should IGF-1R targeted therapy be revisited in Ewing sarcoma? a report of long-term complete response and review of the literatureGeorgios M Stergiopoulos, Brittany L Siontis, Safia K Ahmed, et al.
Cancers|September 28, 2024
Tolerability and Outcomes for Treatment of Older Myxoid Liposarcoma PopulationReilly A Coombs, Judith Jebastin Thangaiah, Brittany L Siontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumorsM A Dickson, S H Okuno, M L Keohan, et al.
American Journal of Clinical Oncology|June 17, 2017
Extraskeletal Osteosarcoma: Outcomes and the Role of ChemotherapyJonas Paludo, Karen Fritchie, Candace L Haddox, et al.
Annals of Surgical Oncology|November 15, 2007
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysisImran Hassan, Y Nancy You, Roman Shyyan, et al.
Oncology|June 1, 2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaKristen N Ganjoo, Lee D Cranmer, James E Butrynski, et al.
Pageof 23